InnoCan Pharma Corporation (INNO.CN) Research

InnoCan Pharma Corporation is a pharmaceutical enterprise dedicated to innovating drug delivery systems that integrate cannabidiol (CBD) with other pharmaceutical compounds. Its operations and development efforts span across the United States, Poland, France, and various international markets. The company actively pursues research and development into treatments for conditions such as COVID-19, leveraging CBD delivered via exosomes and liposomes. InnoCan's product line features a range of CBD-infused topical items, including eye serum, face oil, face cream, facial serum, sleeping mask, recovery lotion, and the Relief & Go spray. Beyond R&D, the corporation is also involved in the marketing and distribution of its proprietary CBD-enhanced pharmaceutical and cosmetic offerings. Established in 2018, InnoCan Pharma Corporation maintains its principal office in Calgary, Canada.

Market snapshot

Symbol
INNO.CN
Price
$3.15
Day change
-1.56%
Market cap
$10.0M
P/E ratio
-6.74x
52-week range
3.01-21
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic

Peer companies

  • BioNxt Solutions Inc. (BNXT.CN)
  • C21 Investments Inc. (CXXI.CN)
  • Decibel Cannabis Company Inc. (DB.V)
  • iAnthus Capital Holdings, Inc. (IAN.CN)
  • Leef Brands Inc. (LEEF.CN)
  • Medexus Pharmaceuticals Inc. (MDP.TO)
  • MariMed Inc. (MRMD.CN)
  • Planet 13 Holdings Inc. (PLTH.CN)

Open InnoCan Pharma Corporation (INNO.CN) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.